Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

1.

Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within seven days.

Hermans FJ, Bruijn MM, Vis JY, Wilms FF, Oudijk MA, Porath MM, Scheepers HC, Bloemenkamp KW, Bax CJ, Cornette JM, Nij Bijvanck BW, Franssen MT, Vandenbussche FP, Kok M, Grobman WA, Van Der Post JA, Bossuyt PM, Opmeer BC, Mol BW, Schuit E, Van Baaren GJ.

Acta Obstet Gynecol Scand. 2015 Apr 3. doi: 10.1111/aogs.12643. [Epub ahead of print]

PMID:
25845495
2.

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.

Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KW, Scheepers HC, Bremer HA, Rijnders RJ, van Loon AJ, Perquin DA, Sporken JM, Papatsonis DN, van Huizen ME, Vredevoogd CB, Brons JT, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BW, Franssen MT, Langenveld J; HYPITAT-II study group.

Lancet. 2015 Mar 24. pii: S0140-6736(14)61998-X. doi: 10.1016/S0140-6736(14)61998-X. [Epub ahead of print]

PMID:
25817374
3.

Patient controlled analgesia with remifentanil versus epidural analgesia in labour: randomised multicentre equivalence trial.

Freeman LM, Bloemenkamp KW, Franssen MT, Papatsonis DN, Hajenius PJ, Hollmann MW, Woiski MD, Porath M, van den Berg HJ, van Beek E, Borchert OW, Schuitemaker N, Sikkema JM, Kuipers AH, Logtenberg SL, van der Salm PC, Oude Rengerink K, Lopriore E, van den Akker-van Marle ME, le Cessie S, van Lith JM, Struys MM, Mol BW, Dahan A, Middeldorp JM.

BMJ. 2015 Feb 23;350:h846. doi: 10.1136/bmj.h846.

4.

Impact of a randomized trial on maintenance tocolysis on length of hospital admission of women with threatened preterm labor in The Netherlands.

Lange TS, Roos C, Bloemenkamp KW, Bolte AC, Duvekot JJ, Franssen MT, Kok M, Oudijk MA, Porath MM, van der Post JA, Mol BW.

Eur J Obstet Gynecol Reprod Biol. 2015 Mar;186:8-11. doi: 10.1016/j.ejogrb.2014.12.003. Epub 2014 Dec 12.

PMID:
25596476
5.

Maternal allopurinol administration during suspected fetal hypoxia: a novel neuroprotective intervention? A multicentre randomised placebo controlled trial.

Kaandorp JJ, Benders MJ, Schuit E, Rademaker CM, Oudijk MA, Porath MM, Oetomo SB, Wouters MG, van Elburg RM, Franssen MT, Bos AF, de Haan TR, Boon J, de Boer IP, Rijnders RJ, Jacobs CJ, Scheepers LH, Gavilanes DA, Bloemenkamp KW, Rijken M, van Meir CA, von Lindern JS, Huisjes AJ, Bakker SC, Mol BW, Visser GH, Van Bel F, Derks JB.

Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F216-23. doi: 10.1136/archdischild-2014-306769. Epub 2014 Dec 15.

PMID:
25512466
6.

Randomized Comparison of Nifedipine and Placebo in Fibronectin-Negative Women with Symptoms of Preterm Labor and a Short Cervix (APOSTEL-I Trial).

Vis JY, van Baaren GJ, Wilms FF, Oudijk MA, Kwee A, Porath MM, Scheepers HC, Spaanderman ME, Bloemenkamp KW, van Lith JM, Bolte AC, Bax CJ, Cornette J, Duvekot JJ, Nij Bijvank SW, van Eyck J, Franssen MT, Sollie KM, Woiski M, Vandenbussche FP, van der Post JA, Bossuyt PM, Opmeer BC, Mol BW.

Am J Perinatol. 2015 Apr;32(5):451-60. doi: 10.1055/s-0034-1390346. Epub 2014 Dec 8.

PMID:
25486290
7.

Pharmacokinetics of nifedipine slow-release during sustained tocolysis.

Ter Laak MA, Roos C, Touw DJ, van Hattum PR, Kwee A, Lotgering FK, J Mol BW, van Pampus MG, Porath MM, Spaanderman ME, van der Post JA, Papatsonis DN, van 't Veer NE.

Int J Clin Pharmacol Ther. 2015 Jan;53(1):84-91. doi: 10.5414/CP202215.

PMID:
25407260
8.

Mid-trimester cervical length as a risk indicator for caesarean delivery in women with a twin pregnancy.

van de Mheen L, Schuit E, Liem SM, Lim AC, Bekedam DJ, Goossens SM, Franssen MT, Porath MM, Oudijk MA, Bloemenkamp KW, Duvekot JJ, Woisky MD, de Graaf I, Sikkema JM, Schepers L, van Eijk J, de Groot CJ, van Pampus MG, Mol BW.

Ultrasound Obstet Gynecol. 2014 Nov 17. doi: 10.1002/uog.14727. [Epub ahead of print]

PMID:
25402630
9.

Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials.

Tajik P, van der Ham DP, Zafarmand MH, Hof MH, Morris J, Franssen MT, de Groot CJ, Duvekot JJ, Oudijk MA, Willekes C, Bloemenkamp KW, Porath M, Woiski M, Akerboom BM, Sikkema JM, Nij Bijvank B, Mulder AL, Bossuyt PM, Mol BW.

BJOG. 2014 Sep;121(10):1263-72; discussion 1273. doi: 10.1111/1471-0528.12889. Epub 2014 May 27.

PMID:
24862166
10.

What is the risk of preterm delivery after arrested preterm labor?

Wilms FF, Vis JY, de Wit-Zuurendonk L, Porath MM, Mol BW.

Am J Perinatol. 2015 Jan;32(1):63-70. doi: 10.1055/s-0034-1374818. Epub 2014 May 16.

PMID:
24839150
11.

Predictive value of cervical length measurement and fibronectin testing in threatened preterm labor.

van Baaren GJ, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers HC, Spaanderman ME, Bloemenkamp KW, Haak MC, Bolte AC, Bax CJ, Cornette JM, Duvekot JJ, Nij Bijvanck BW, van Eyck J, Franssen MT, Sollie KM, Vandenbussche FP, Woiski M, Grobman WA, van der Post JA, Bossuyt PM, Opmeer BC, Mol BW.

Obstet Gynecol. 2014 Jun;123(6):1185-92. doi: 10.1097/AOG.0000000000000229.

PMID:
24807328
12.

Prediction of preterm birth in multiple pregnancies: development of a multivariable model including cervical length measurement at 16 to 21 weeks' gestation.

van de Mheen L, Schuit E, Lim AC, Porath MM, Papatsonis D, Erwich JJ, van Eyck J, van Oirschot CM, Hummel P, Duvekot JJ, Hasaart TH, Groenwold RH, Moons KG, de Groot CJ, Bruinse HW, van Pampus MG, Mol BW.

J Obstet Gynaecol Can. 2014 Apr;36(4):309-19.

PMID:
24798668
13.

Midtrimester preterm prelabour rupture of membranes (PPROM): expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial).

van Teeffelen AS, van der Ham DP, Willekes C, Al Nasiry S, Nijhuis JG, van Kuijk S, Schuyt E, Mulder TL, Franssen MT, Oepkes D, Jansen FA, Woiski MD, Bekker MN, Bax CJ, Porath MM, de Laat MW, Mol BW, Pajkrt E.

BMC Pregnancy Childbirth. 2014 Apr 4;14:128. doi: 10.1186/1471-2393-14-128.

14.

Can neonatal sepsis be predicted in late preterm premature rupture of membranes? Development of a prediction model.

van der Ham DP, van Kuijk S, Opmeer BC, Willekes C, van Beek JJ, Mulder AL, van Loon AJ, Groenewout M, Mantel GD, Bloemenkamp KW, Porath M, Kwee A, Akerboom BM, Papatsonis DN, Metz GC, Nijhuis JG, Mol BW; PPROMEXIL trial group.

Eur J Obstet Gynecol Reprod Biol. 2014 May;176:90-5. doi: 10.1016/j.ejogrb.2014.02.003. Epub 2014 Feb 13.

PMID:
24630296
15.

Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).

van Vliet EO, Schuit E, Heida KY, Opmeer BC, Kok M, Gyselaers W, Porath MM, Woiski M, Bax CJ, Bloemenkamp KW, Scheepers HC, Jaquemyn Y, van Beek E, Duvekot HJ, Franssen MT, Bijvank BN, Kok JH, Franx A, Mol BW, Oudijk MA.

BMC Pregnancy Childbirth. 2014 Mar 3;14:93. doi: 10.1186/1471-2393-14-93.

16.

Prediction of postpartum hemorrhage in women with gestational hypertension or mild preeclampsia at term.

Koopmans CM, van der Tuuk K, Groen H, Doornbos JP, de Graaf IM, van der Salm PC, Porath MM, Kuppens SM, Wijnen EJ, Aardenburg R, van Loon AJ, Akerboom BM, van der Lans PJ, Mol BW, van Pampus MG; HYPITAT study group.

Acta Obstet Gynecol Scand. 2014 Apr;93(4):399-407. doi: 10.1111/aogs.12352.

PMID:
24575790
17.

Peri-partum reference ranges for ROTEM(R) thromboelastometry.

de Lange NM, van Rheenen-Flach LE, Lancé MD, Mooyman L, Woiski M, van Pampus EC, Porath M, Bolte AC, Smits L, Henskens YM, Scheepers HC.

Br J Anaesth. 2014 May;112(5):852-9. doi: 10.1093/bja/aet480. Epub 2014 Jan 31.

PMID:
24486836
18.

Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial.

Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de Groot CA, Akerboom BM, van Alphen M, Bloemenkamp KW, Boers KE, Bremer HA, Kwee A, van Loon AJ, Metz GC, Papatsonis DN, van der Post JA, Porath MM, Rijnders RJ, Roumen FJ, Scheepers HC, Schippers DH, Schuitemaker NW, Stigter RH, Woiski MD, Mol BW, van Rhenen DJ, Duvekot JJ.

BJOG. 2014 Jul;121(8):1005-14. doi: 10.1111/1471-0528.12531. Epub 2014 Jan 10.

PMID:
24405687
19.

Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial).

Vijgen SM, van der Ham DP, Bijlenga D, van Beek JJ, Bloemenkamp KW, Kwee A, Groenewout M, Kars MM, Kuppens S, Mantel G, Molkenboer JF, Mulder AL, Nijhuis JG, Pernet PJ, Porath M, Woiski MD, Weinans MJ, van Wijngaarden WJ, Wildschut HI, Akerboom B, Sikkema JM, Willekes C, Mol BW, Opmeer BC; PPROMEXIL study group.

Acta Obstet Gynecol Scand. 2014 Apr;93(4):374-81. doi: 10.1111/aogs.12329. Epub 2014 Jan 29.

PMID:
24392746
20.

Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labour.

Kaandorp JJ, van den Broek MP, Benders MJ, Oudijk MA, Porath MM, Bambang Oetomo S, Wouters MG, van Elburg R, Franssen MT, Bos AF, Mol BW, Visser GH, van Bel F, Rademaker CM, Derks JB; ALLO-trial Study Group.

Arch Dis Child Fetal Neonatal Ed. 2014 Mar;99(2):F144-8. doi: 10.1136/archdischild-2013-304876. Epub 2013 Dec 18.

PMID:
24352085
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk